Peter K. Harris

2.0k total citations · 1 hit paper
33 papers, 1.3k citations indexed

About

Peter K. Harris is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter K. Harris has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter K. Harris's work include Cancer Genomics and Diagnostics (12 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Head and Neck Cancer Studies (4 papers). Peter K. Harris is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Head and Neck Cancer Studies (4 papers). Peter K. Harris collaborates with scholars based in United States, Germany and India. Peter K. Harris's co-authors include David M. Kurnit, Timothy A. Donlon, Rachael L. Neve, Kenneth S. Kosik, John L. Woolford, John L. Teem, Michael Rosbash, Aadel A. Chaudhuri, Abul Usmani and S. Elaine Barrie and has published in prestigious journals such as Cell, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Peter K. Harris

29 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma

2022 180 citations Alexander X. Lozano, Aadel A. Chaudhuri et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter K. Harris United States	14	620	307	267	239	175	33	1.3k
Aimin Li China	18	1.0k 1.6×	563 1.8×	155 0.6×	259 1.1×	115 0.7×	33	1.6k
Brenda Salumbides United States	15	955 1.5×	277 0.9×	281 1.1×	287 1.2×	218 1.2×	24	1.5k
Izabela Piotrowska United Kingdom	16	731 1.2×	105 0.3×	363 1.4×	153 0.6×	185 1.1×	19	1.5k
Andrey Frolov United States	17	477 0.8×	246 0.8×	351 1.3×	143 0.6×	114 0.7×	30	1.1k
Maria Pinzon-Ortiz United States	8	599 1.0×	258 0.8×	443 1.7×	148 0.6×	326 1.9×	18	1.2k
Beth R. Pflug United States	21	558 0.9×	148 0.5×	237 0.9×	312 1.3×	298 1.7×	33	1.2k
Umadevi V. Wesley United States	18	561 0.9×	140 0.5×	440 1.6×	234 1.0×	202 1.2×	28	1.2k
Xiaoai Zhao China	13	575 0.9×	163 0.5×	167 0.6×	231 1.0×	75 0.4×	20	1.1k
Elmar Kirches Germany	27	1.2k 1.9×	139 0.5×	287 1.1×	316 1.3×	243 1.4×	103	2.3k
Susan Giblett United Kingdom	17	695 1.1×	325 1.1×	262 1.0×	100 0.4×	71 0.4×	25	1.3k

Countries citing papers authored by Peter K. Harris

Since Specialization

Citations

This map shows the geographic impact of Peter K. Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter K. Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter K. Harris more than expected).

Fields of papers citing papers by Peter K. Harris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter K. Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter K. Harris. The network helps show where Peter K. Harris may publish in the future.

Co-authorship network of co-authors of Peter K. Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Peter K. Harris. A scholar is included among the top collaborators of Peter K. Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter K. Harris. Peter K. Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chatterjee, Deep, et al.. (2025). Rapid parameter estimation for kilonovae using likelihood-free inference. Monthly Notices of the Royal Astronomical Society. 541(3). 2619–2630.

Winckler, Wendy, Noah Earland, Peter K. Harris, et al.. (2024). Abstract 961: Detection of minimal residual disease in lymph predicts recurrence in HPV-negative head and neck cancer patients. Cancer Research. 84(6_Supplement). 961–961.

Earland, Noah, Nicholas P. Semenkovich, Ricardo J. Ramirez, et al.. (2023). Sensitive MRD Detection from Lymphatic Fluid after Surgery in HPV-Associated Oropharyngeal Cancer. Clinical Cancer Research. 30(7). 1409–1421. 7 indexed citations

Dang, Ha X., Pradeep S. Chauhan, Wenjia Feng, et al.. (2023). PACT: a pipeline for analysis of circulating tumor DNA. Bioinformatics. 39(8). 1 indexed citations

Morrissey, Jeremiah J., Prashant Gupta, Pradeep S. Chauhan, et al.. (2023). Preservation of Proteins in Human Plasma through Metal–Organic Framework Encapsulation. ACS Applied Materials & Interfaces. 15(15). 18598–18607. 3 indexed citations

Lozano, Alexander X., Aadel A. Chaudhuri, Aishwarya Nene, et al.. (2022). T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma. Nature Medicine. 28(2). 353–362. 180 indexed citations breakdown →

Manjunath, Yariswamy, Kanve N. Suvilesh, Jonathan B. Mitchem, et al.. (2022). Circulating Tumor-Macrophage Fusion Cells and Circulating Tumor Cells Complement Non–Small-Cell Lung Cancer Screening in Patients With Suspicious Lung-RADS 4 Nodules. JCO Precision Oncology. 6(6). e2100378–e2100378. 9 indexed citations

Chauhan, Pradeep S., Ha X. Dang, Elisa M. Ledet, et al.. (2022). Liquid biopsy AR/enhancer alteration detection before AR-targeted therapy and correlation with survival in metastatic castrate-resistant prostate cancer patients.. Journal of Clinical Oncology. 40(6_suppl). 171–171.

Xu, Zhongping, Noah Earland, Peter K. Harris, et al.. (2022). Human papillomavirus DNA resides in surgical drain fluid exosomes from HPV+ oropharyngeal squamous cell carcinoma patients and can be spread to neighboring HPV-negative cells.. Journal of Clinical Oncology. 40(16_suppl). e18050–e18050. 1 indexed citations

10.

Chauhan, Pradeep S., Kevin Chen, Wenjia Feng, et al.. (2021). Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study. PLoS Medicine. 18(8). e1003732–e1003732. 55 indexed citations

11.

Chen, Kevin, Pradeep S. Chauhan, Wenjia Feng, et al.. (2021). Tracking minimal residual disease with urine tumor DNA in muscle-invasive bladder cancer after neoadjuvant chemotherapy.. Journal of Clinical Oncology. 39(15_suppl). e16514–e16514. 3 indexed citations

12.

Chen, Kevin, Misty Dawn Shields, Pradeep S. Chauhan, et al.. (2021). Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors. Molecular Diagnosis & Therapy. 25(6). 757–774. 36 indexed citations

13.

Chauhan, Pradeep S., Wenjia Feng, Peter K. Harris, et al.. (2020). Urinary Tumor DNA Detection of Muscle-Invasive Bladder Cancer May be Superior to Surgical Pathologic Complete Response Status for Predicting Survival Outcomes. International Journal of Radiation Oncology*Biology*Physics. 108(3). e916–e916. 1 indexed citations

14.

Chin, R, Abul Usmani, Peter K. Harris, et al.. (2019). Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA). Molecular Diagnosis & Therapy. 23(3). 311–331. 126 indexed citations

15.

Jones, Darin E., et al.. (2015). Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets. Bioorganic & Medicinal Chemistry. 23(10). 2328–2343. 24 indexed citations

16.

Parlow, John J., Brenda L. Case, Thomas Girard, et al.. (2010). Part II: Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation. Bioorganic & Medicinal Chemistry Letters. 20(4). 1388–1394. 14 indexed citations

17.

Parlow, John J., Brenda L. Case, Thomas Girard, et al.. (2010). Piperazinyl Glutamate Pyridines as Potent Orally Bioavailable P2Y₁₂ Antagonists for Inhibition of Platelet Aggregation. Journal of Medicinal Chemistry. 53(5). 2010–2037. 40 indexed citations

18.

Rosbash, Michael, Peter K. Harris, John L. Woolford, & John L. Teem. (1981). The effect of temperature-sensitive RNA mutants on the transcription products from cloned ribosomal protein genes of yeast. Cell. 24(3). 679–686. 183 indexed citations

19.

Barrie, S. Elaine & Peter K. Harris. (1977). Myocardial enzyme activities in guinea pigs during development. American Journal of Physiology-Heart and Circulatory Physiology. 233(6). H707–H710. 31 indexed citations

20.

Gibson, K, et al.. (1975). Some properties of rat myocardial ornithine decarboxylase and the in vitro effects of nucleotides.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 7. 77–83. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact